Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer - Top-Institutions - MDSpire

Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer

  • By

  • Lars Haack

  • David Krug

  • Severin Rodler

  • Philipp Nuhn

  • Christof van der Horst

  • Christian Schulz

  • Olaf Wittenstein

  • Claudia Schmalz

  • Oliver Blanck

  • Frank-André Siebert

  • Alexander Fabian

  • April 9, 2025

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Patient-Reported Outcomes Research

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Prostate Cancer Research
    • Health Outcomes

  • #3

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Radiation Oncology
    • Urology
    • Patient-Centered Outcomes

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Radiation Oncology
    • Prostate Cancer
    • Health Services Research

  • #5

    German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ)

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Radiation Oncology
    • Cancer Epidemiology
    • Patient-Reported Outcomes

Original Source(s)

Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer

  • by Lars Haack, David Krug, Severin Rodler, Philipp Nuhn, Christof van der Horst, Christian Schulz, Olaf Wittenstein, Claudia Schmalz, Oliver Blanck, Frank-André Siebert, Alexander Fabian

  • April 9, 2025

Related Content

Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

Adjuvant vs Salvage Radiation Therapy for Prostate Cancer: New Data

Dr. Jessica Karen Wong presents a discussion on Adjuvant vs Salvage Radiation Therapy for Prostate Cancer: New Data.

  • July 19, 2021

  • 1 min
Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study